WHERE TO BE

10+ can't-miss Houston business and innovation events for September

Check out these conferences, pitch competitions, networking, and more all happening in September. Photo via Getty Images

From networking meetups to pitch competitions, September has a smorgasbord of opportunities for Houston innovators.

Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Note: This post might be updated to add more events.

Mark your calendars for November 8 for the annual Houston Innovation Awards, and nominate your company or another deserving business by September 19.

September 5 — Tech + Tequila Talk: Houston Innovation

Natara Branch, CEO of Houston Exponential, will delve into the most recent developments within the Houston Innovation Community, shedding light on Houston Exponential's latest initiatives. She will also provide insights into upcoming events, including the highly-anticipated Tech Rodeo and the forthcoming Innovation Awards Gala. After all of that education and conversation, unwind with an authentic tequila tasting and network with tech industry peers.

The agenda:

5:50 pm - 6 pm: Sign-in/Registration

6 pm - 6:30 pm: Tequila tasting

6:30 pm - 7 pm: Tech talk

7 pm - 8 pm: Networking & Tequilas

This event is Tuesday, September 5, from 6 pm to 8 pm at the Ion. Click here to register.

September 7 — Venture Houston 2023

Venture Houston 2023 is a major event for entrepreneurs, venture investors and ecosystem builders to plug into what is happening in Houston. Come learn how you can decarbonize in a digital world, connect with Houston's best founders, corporate leaders and top tier investors, and develop meaningful relationships.

The agenda:

7 am - 8:45 am: Registration

8:45 am - 12:30 pm: General Programming

12:30 pm - 1:45 pm: Networking Lunch

2:00 pm - 4:15 pm: General Programming

4:15 pm - 6 pm: Networking Cocktail Reception

This event is Thursday, September 7, from 7 am to 6 pm at Stude Concert Hall. Click here to register.

September 8 — Inspire & Transform: Celebrating Women In Data

Hosted by the Houston Chapter of Women in Data and Solidatus, this event will feature influential women who have made significant contributions to the field of data from the City of Houston, Exxon, EY, Google, Houston Methodist and more. The event will discuss and debate "The Intersection of Data, AI and Sustainability" and "What Does Good Look Like" through insightful panel discussions, and networking opportunities. Price of admission is $10.

The agenda:

9 am - Check-in and Network

9:15 am - Welcome

9:20 am - Panel 1: The Intersection of Data, AI & Sustainability

10 am - Networking Break

10:10am - Panel 2: "What Does Good Look Like"

10:45am - Scholarships Awarded

11am - End of event + Networking Opportunities

This event is Friday, September 8, from 9 am to 11 am at 200 Park Place. Click here to register.

September 9 — Revolutionizing Your Work: Eight Innovative Ways Entrepreneurs Can Leverage ChatGPT & AI to Scale, Grow & Succeed

Discover how successful entrepreneurs are harnessing the power of artificial intelligence and ChatGPT to drive their businesses forward. At this event, you'll gain valuable insights from industry experts who have leveraged AI and ChatGPT to grow, scale, and succeed. Learn how these technologies can enhance customer experiences, streamline operations, and drive innovation in your own entrepreneurial journey.

This event is Saturday, September 9, from 12:30 to 1:30pm at The R.O.C.K. - Broadway Campus. Click here to register.

September 13 — Small Business Exchange

The Small Business Exchange, powered by US SBA, is a lively and informative event designed to connect small business owners and entrepreneurs.

At the Small Business Exchange, you'll have the opportunity to network with like-minded individuals, share your experiences, and gain valuable insights from industry experts. Whether you're a seasoned business owner or just starting out, this event offers a unique chance to learn, grow, and collaborate.


This event is Wednesday, September 13, from 11 am to 2 pm at SBDC Office. Click here to register.

September 21 — 20th Rice Alliance Energy Tech Venture Forum

The Energy Tech Venture Forum, hosted by The Rice Alliance for Technology and Entrepreneurship, will showcase energy tech innovations to shift towards a more sustainable, reliable and lower carbon future across interactive panels, inspiring keynotes and over 50 dynamic venture pitches, leaders.

At the 20th annual conference, discover more than 90 new technology ventures commercializing energy transition innovations and meet investors looking for disruptive energy technologies that can accelerate clean and renewable energy. Check to see if you are a Rice Alliance member or sponsor to confirm your free registration. Rice university faculty and staff can also attend for free. For non-Rice community members tickets are $245.

This event is Thursday, September 21, from 7:30 am to 5:15 pm at Rice University. Click here to register.

September 21 — UH Energy Symposium: Plastics, Chemicals, Circularity: What’s Next?

Focusing on the multifaceted nature and enormity of the challenge, this discussion will focus on what circularity means for the future of production and consumption, meeting consumer demand, and creating and preserving utility across the value chain, while addressing emissions reduction and waste management through new technologies, standards, regulatory mechanisms like extended producer responsibility, and stakeholder engagement.

This event is Thursday, September 21, from 6 to 7:30 pm at the University of Houston. Click here to register.

September 22 — Future of Technology

This year's Greater Houston Partnership event revolves around one of the most talked about trends in tech - artificial intelligence. With rapidly growing adoption of AI across industry and everyday applications, this timely conversation explores the possibilities and challenges unlocked by AI.

This event is Friday, September 22, from 11 am to 1:30 pm at Omni Houston. Click here to register.

September 23 — OPEN Houston 11th Annual Conference

Head over to the OPEN Houston 11th annual conference which will focus on the important players building Houston’s emerging technology and startup ecosystem. Hear from and connect with the founders, executives, investors, and other leaders that are building Houston’s innovation economy. Admission is $25-$50.

The agenda:

9:00 AM - 10.00 AM - Registration

10.00 AM - 10:30 AM - Mayor Sylvester Turner Welcoming

10:30 AM - 11:30 AM - Keynote by Andrew Yang

11:30 AM - 12:30 PM - Founder’s Panel

12:30 PM - 1:30 PM - Lunch

1:30 PM - 3:30 PM - Business Pitch Competition

3:30 PM - 3:45 PM - Award Ceremony

3:45 PM - 4:00 PM - Happy Hour

This event is Saturday, September 23, from 9 am to 4 pm at Moran Hotel. Click here to register.

September 27 — Space IT UP: Demo Day

Presented by ITA and ASI in collaboration with the Space Foundation, this event celebrates the journey of six Italian companies as they launch their groundbreaking space ventures from Houston's thriving space ecosystem. Following a five-week accelerator program, these companies will be pitching their innovative space solutions at this Demo Day.

This event is Wednesday, September 27 , from 5:30 to 8 pm at the Ion. Click here to register.

September 27 — Pearland Innovation Hub Grand Opening

Come learn more about the Pearland Innovation Hub, tour the new space, and celebrate the expansion. Raffle prizes will be available for attendees and f ood and drinks will be provided for registered attendees.

This event is Wednesday, September 27, from 6 to 8 pm at Pearland Innovation Hub. Click here to register.

September 28 — Chevron Technology Ventures Pitch Competition

Chevron is looking for novel technologies or approaches that can be applied to transform their operations. With the goal of removing people from hazardous environments (e.g., confined spaces, working at heights), reducing the environmental impact (e.g., leak detection, emissions monitoring), and increasing the operational efficiency (e.g., autonomous operations, advanced inspection capabilities, predictive asset health capabilities) of their facilities in the decades to come.

Registered attendees will be able to take a tour of the Chevron workspaces within the Cannon West Houston, enjoy refreshments and network.

This event is Thursday, September 28, from 4 to 7:30 pm at the Cannon. Click here to register.

Trending News

 
 

Promoted

Emerson Perin of the Texas Heart Institute, recently published the largest clinical trial of cell therapy for patients with chronic heart failure to-date included 580 patients at 52 sites throughout North America. Photo via texasheart.org

Emerson Perin’s end goal isn’t to treat heart failure. The medical director of The Texas Heart Institute says that he has his sights set firmly on curing the malady altogether. And, with the power of innovation and a strong team, the Houston-based cardiologist has a good chance of meeting his objective.

Perin first came to THI for fellowship training in 1988, following his residency in Miami and medical school in his birthplace of Brazil.

“This is a very special place,” the physician and researcher, whose titles also include director for THI’s Center for Clinical Research and vice president for medical affairs, tells InnovationMap. “It has a worldwide-reaching reputation. I’ve always liked research and this is a great place in terms of innovation and practicing high-level cardiology.”

For decades, Perin has followed in THI founder Denton Cooley’s footsteps with world-changing research. In 2001, the founding medical director of THI’s Stem Cell Center was the first person to inject stem cells into a failing human heart. It led to a trial of 17 patients that year.

“A couple of the patients did remarkably well — more than you could ever expect. These guys who couldn’t’ walk across the room pretty much were jogging on the beach. That gave me the initial insight that this works,” Perin recalls.

What exactly is heart failure? The term refers to the condition of a heart that can’t pump enough blood to sustainably power the body through oxygenation of the tissues from blood flow. It may sound like a death sentence, but with appropriate care, it can usually be managed with medicines and if worsening occurs, devices and, ultimately, heart transplantation.

And Perin is proving that there’s a lot of life ahead for heart failure patients. Earlier this year, he published another groundbreaking clinical trial, DREAM-HF. The largest clinical trial of cell therapy for patients with chronic heart failure to-date included 580 patients at 52 sites throughout North America.

With the goal of getting a new cell therapy approved for heart failure, the primary endpoint was to prove that the therapy could prevent recurrent hospitalizations.

“It was a total negative,” says Perin. That’s because the cells don’t have a decongestant effect such as the medicines currently used to treat heart failure.

But that doesn’t mean that the trial was a failure. Quite the opposite. That’s because Perin and his team proved something else: The trial was able to prove that there was significant improvement in patients with inflammation. After those patients were injected with mesenchymal precursor cells (MPC), they showed a 70-percent reduction in heart attacks and strokes. Cardiovascular deaths also decreased.

These are blockbuster numbers, and big news for patients dealing with heart failure. What it means is that the cells addressed a different aspect of heart failure that until now had been left untreated which was the inflammation — how heart failure starts and what keeps it going.

So what’s next? Going to the FDA.

“They said, ‘We can’t approve it with one trial, but we’ll approve it with two,’” says Perin.

This time, his primary endpoint will be tailored to suit the positive outcome he knows he’ll be able achieve. This next round will begin in 2024.

Once the FDA approves a new catheter system for injecting the heart with stem cells and genes, the team will proceed with new studies. Gene therapy will be another frontier for Perin — and patients with heart failure.

“I think the combination of cells and genes is even more powerful,” he says. “That will help save lives in a completely new way and do away with heart failure.”

Perin's work is just one piece of the puzzle, and Dr. Joseph Rogers, who was appointed president and CEO of THI in 2021, is leading the organization's initiative in several ways. THI, recently buoyed by a $32 million donation from a patient — the largest charitable donation in its history — is exploring several innovative therapeutics, devices, and treatments.

THI recently received a two-year, $1.14 million grant from The National Heart, Lung, and Blood Institute to develop a novel, first-in-class drug to treat the cardiovascular disease that arises from atherosclerosis. Another THI innovator, Camila Hochman-Mendez — along with her research team — is studying the effects of regenerative medicine on hearts.

Trending News

 
 

Promoted